Availability of the Essential Medicines is Community Pharmacies: A Cross-Sectional Study
- 1,
- 1,
- 1,
- 2,
- 1,
- 1*
- 1Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India.
- 2Department of Community and Family Medicine, All India Institute of Medical Sciences, Jodhpur, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Jaykaran Charan
Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India.
Email: dr.jaykaran78@gmail.com
Copyright: © 2022 The Author(s). This is an open access article.
Published: Jan 1, 2022, Received: Nov 20, 2021, Accepted: Jan 28, 2022
Abstract
World Health Organization (WHO) defines essential drugs or medicines as “those drugs that satisfy the healthcare needs of majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford.”1 Since 1975, the WHO has taken over its role on the essential drugs, which was initially a mere concept to a well-established policy.2 In the year 1977, the WHO decided to make this concept more concrete, and thus prepared and published a model list of essential drugs which had around 200 drugs including the vaccines.3 The WHO model of the essential medicine list (EML) thus came into force in 1977 and is being updated every two years since then.4 The current version of the list is in its 21st edition, and the essential medicine list for children is in its seventh edition which was last updated in the month of June in the year 2019.5 In the case of India, the first EML was published in 1996.3 The latest list was published in 2015 with 376 drugs.6 Many states also have their respective EML. Rajasthan is one among the many states having their EML. The current EML for the state of Rajasthan was published in the year 2019 which comprises 608 drugs.7 Looking at the importance of EML for patient care, it is important to ascertain that these drugs are available easily at community pharmacies at affordable cost. As per the various previous published studies, many drugs from EML are not available in community and hospital pharmacies.8–11 A study done by Rathish et al.8 in a rural Sri Lankan district found out that there was a discrepancy in the availability of essential medicines among the base hospitals and central dispensary. It was also noted that the availability of drugs for different clinical conditions also varied considerably.8 Another study done by Chandani et al.9 in Ethiopia, Malawi, and Rwanda stated that the availability of drugs was much fragile in different countries.9 Tripathi et al.10 conducted a study in the state of Chhattisgarh, India, and found out that about 58% of the prescribed medicines were found to be available, and by improving certain factors like the state financial resources, supply chain, and encouraging physicians in prescribing these drugs would certainly lead to the improvement in their overall availability.10 The drugs from the EML should not only be easily available but also be obtainable at an affordable price. A study was done by Faruqui et al.11 in New Delhi, India, on the availability of drugs for chronic illnesses found out that the mean availability did not meet the 80% criteria as proposed by the WHO over all facilities.11 It is very clear that there is an unavailability of robust data related to the availability of different medicines from the EML. This data is very important to know the current status of the availability of essential medicines, and would also prove to be useful in policy-making decisions. Hence, this study was conducted with the aim to assess the availability of essential medicines from central and state lists of essential medicines in community pharmacies. This study was a cross-sectional survey. It was conducted in the community, where private pharmacies were approached with the list of essential medicines (both central and state) and the availability of these medicines were asked. These pharmacies were located near the government and private hospitals. Pharmacies attached to any specific hospitals and government-backed generic drug stores were not included in the study. This study was approved by the Institutional Ethics Committee (AIIMS/IEC/2020/3350). Informed consent was obtained from the owner/pharmacist who provided the information regarding the availability of the medicines at his/her pharmacy. Three government and eight private hospitals were considered to be the survey points, and pharmacies located near to these hospitals were considered to be sampling frames. As no list of these pharmacies were available, each approached the pharmacy willing to participate was included till a feasible sample of 100 pharmacies was saturated. Pharmacists were explained about the study objectives and willingness to participate was sought. The latest version of the national essential medicine list of India (NLEM, 2015) and the essential medicine list of the state of Rajasthan from 2018 to 2019 was used for this study.6,7 The central list has 376 medicines and state EML has 608 medicines. There is a large overlap of medicines between both the lists. After considering the overlap, a list of unique 804 medicines was prepared and pharmacists/owners of the pharmacy were approached with this list and asked about the availability of these medicines. This study was done based on data collected from 100 community pharmacies. Descriptive statistics were reported in the form of frequencies, percentages, mean, standard deviation, and range. Out of all the drugs from the central EML, 83.6% were available, and from Rajasthan EML 72.3% of drugs were available. Of all the anesthetics in the central EML, 56% of drugs were available and 12% showed partial availability. Anti-infective drugs showed 72% availability and 1.4% of them were found to be partially available. Antineoplastic showed 97.2% and 2.8% of availability and partially availability, respectively. Miscellaneous drugs also showed the availability of 46.1% and partial availability of 7.7%. Analgesics, antidotes and other substances, antiepileptics, antimigraine, anti-Parkinson, diuretics, GIT drugs, vitamins, and minerals were available on all pharmacies (Table 1). Of all the categories of drugs in Rajasthan EML, anti-infective drugs showed the availability of 36.2%, and 1.6% of drugs were found to be partially available. For antiallergic drugs, 75% were available and 10% were partially available. Miscellaneous drugs showed 15.8% and 5.2% of availability and partial availability, respectively (Table 2). This study was designed with the aim of evaluating the availability of the drugs from the essential medicine list of India and Rajasthan in the pharmacies. It was found that the majority of the drugs of the essential drug list were available in these pharmacies. As per the WHO, availability of >80% of essential medicines is considered to be adequate and good and this was fulfilled for the majority of drug categories in our study.12 In many such studies available for public health facilities, the availability of drugs from the EML was found to be suboptimal but adequate in the case of private facilities.13,14
Subject
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026